ORIDONIN

/ INGREDIENTS / By
  1. 1-Oxo/Acylation-14-Acylated Oridonin Derivative, Preparation Method Therefor And Application Thereof
  2. A New Method To Extract Oridonin And Rosmarinic Acid Simultaneously From Rabdosia Rubescens
  3. A New Oridonin Analog Suppresses Triple-Negative Breast Cancer Cells And Tumor Growth Via The Induction Of Death Receptor 5
  4. A New Oridonin Analogue Suppresses Triple-Negative Breast Cancer Cells And Tumor Growth Via Inducing The Expression Of Death Receptor 5
  5. A Novel Combination Of Oridonin And Valproic Acid In Enhancement Of Apoptosis Induction Of Hl-60 Leukemia Cells
  6. A Novel Conjunction Of Folate-Targeted Carbon Nanotubes Containing Protohemin And Oridonin-Liposome Loaded Microbubbles For Cancer Chemo-Sonodynamic Therapy
  7. A Novel Potent Anticancer Compound Optimized From A Natural Oridonin Scaffold Induces Apoptosis And Cell Cycle Arrest Through The Mitochondrial Pathway
  8. A Rapid Hplc/Esi-Ms Method For The Quantitative Determination Of Oridonin In Rat Plasma
  9. A Study On Apoptosis Of Human Hct8 Cell Induced By Oridonin
  10. A Study On Apoptosis Of Human Hct8 Cell Induced By Oridonin [J]
  11. A Thiazole-Derived Oridonin Analogue Exhibits Antitumor Activity By Directly And Allosterically Inhibiting Stat3
  12. Abstract P3-06-09: Discovery Of Novel Oridonin-Derivatives For The Treatment Of Metastatic Breast Cancer
  13. Activated Toll-Like Receptor 4 Is Involved In Oridonin-Induced Phagocytosis Via Promotion Of Migration And Autophagy-Lysosome Pathway In Raw264. 7 Macrophages
  14. Activation Of Phosphoinositide 3-Kinase, Protein Kinase C, And Extracellular Signal-Regulated Kinase Is Required For Oridonin-Enhanced Phagocytosis Of Apoptotic …
  15. Allelopathy Of Oridonin On Seed Germination And Seedling Growth Of Arabidopsis Thaliana
  16. Altered Gene Expression Reveals Molecular Mechanisms Underlying Oridonin-Induced Apoptosis Of Multiple Myeloma Lp-1 Cells
  17. An Hplc Method For Determination Of Oridonin In Rabbits Using Isopsoralen As An Internal Standard And Its Application To Pharmacokinetic Studies For Oridonin-Loaded …
  18. Antiangiogenic Effects Of Oridonin
  19. Anticancer Activity Of Oridonin Against Esophageal Cancer Cells Enhanced By Special Electromagnetic Field Treated Water
  20. Anticancer Effects Of Oridonin On Colon Cancer Are Mediated Via Bmp7/P38 Mapk/P53 Signaling
  21. Antifibrosis Effect Of Novel Oridonin Analog Cyd0618 Via Suppression Of The Nf-Κb Pathway
  22. Anti-Inflammatory Effects Of Novel Oridonin Analog Cyd0693 In Rat Cardiomyocytes Via Inhibition Of Nf-Κb Signaling Pathway
  23. Anti-Leukemia Effect And Mechanism Of Oridonin On Imatinib-Sensitive And Imatinib-Resistant K562 Cells
  24. Anti-Leukemia Effect Of Oridonin On Ph (+) Acute Lymphoblastic Leukemia Cell Sup-B15
  25. Anti-Leukemia Effect Of Oridonin On T-Cell Acute Lymphoblastic Leukemia
  26. Anti-Proliferation Effect Of Oridonin On Hl-60 Cells And Its Mechanism.
  27. Antiproliferation Effects Of Oridonin On Hl-60 Cells
  28. Antiproliferation Effects Of Oridonin On Hpb‐All Cells And Its Mechanisms Of Action
  29. Antiproliferation Effects Of Oridonin On Human Pancreatic Carcinoma Sw1990 Cells [J]
  30. Antiproliferation Effects Of Oridonin On Leukemic Hl-60 Cells And Its Mechanism [J]
  31. Anti-Proliferative Effects Of Oridonin On Spc-A-1 Cells And Its Mechanism Of Action
  32. Anti-Tumor Activity And Mechanism Of Oridonin [J]
  33. Antitumor Activity Of Acylated Oridonin
  34. Anti-Tumor Activity Of Oridonin On Snu-5 Subcutaneous Xenograft Model Via Regulation Of C-Met Pathway
  35. Antitumor And Antibacterial Derivatives Of Oridonin: A Main Composition Of Dong-Ling-Cao
  36. Antitumor Effect Of Chinese Herb Oridonin On Human Non-Small Cell Lung Cancer (Nsclc).
  37. Anti-Tumor Effect Of Tanshinone Ii A, Tetrandrine, Honokiol, Curcumin, Oridonin And Paeonol On Leukemia Cell Lines
  38. Apoptosis Inducing And Differentiation Enhancement Effect Of Oridonin On The All‐Trans‐Retinoic Acid‐Sensitive And‐Resistant Acute Promyelocytic Leukemia Cells
  39. Apoptosis-Suppressing And Autophagy-Promoting Effects Of Calpain On Oridonin-Induced L929 Cell Death
  40. Apoptotic Effect Of Oridonin On Ej Cells And Its Mechanisms
  41. Apoptotic Effect Of Oridonin On Hl-60 Cells And Its Mechanism
  42. Apoptotic Effect Of Oridonin On Nb4 Cells And Its Mechanism
  43. Apoptotic Effect Of Oridonin On T24 Cells And Its Mechanisms [J]
  44. Application Of Oridonin In Medicine Preparation
  45. Application Of Oridonin In Preparing Medicaments For Promoting Surrounding Vascellum Tunica Interna Incrassation
  46. Assessment Of Chemopreventive Effect Of Oridonin Extract On Oral Squamous Cell Carcinoma Cell Line
  47. Augmentation Of Oridonin-Induced Apoptosis Observed With Reduced Autophagy
  48. Autophagy Counteracts Apoptosis In Human Multiple Myeloma Cells Exposed To Oridonin In Vitro Via Regulating Intracellular Ros And Sirt1
  49. Autophagy Enhanced Phagocytosis Of Apoptotic Cells By Oridonin-Treated Human Histocytic Lymphoma U937 Cells
  50. Autophagy Inhibits Reactive Oxygen Species‐Mediated Apoptosis Via Activating P38‐Nuclear Factor‐Kappa B Survival Pathways In Oridonin‐Treated Murine Fibrosarcoma …
  51. Autophagy Of Prostate Cancer Pc-3 Cells Under The Induction Of Oridonin
  52. Autophagy Preceded Apoptosis In Oridonin-Treated Human Breast Cancer Mcf-7 Cells
  53. Back To The Future Of Oridonin: Again, Compound From Medicinal Herb Shows Potent Antileukemia Efficacies In Vitro And In Vivo
  54. Bcl-2 Up-Regulation And P-P53 Down-Regulation Account For The Low Sensitivity Of Murine L929 Fibrosarcoma Cells To Oridonin-Induced Apoptosis
  55. Beneficial Effects Of Oridonin On Myocardial Ischemia/Reperfusion Injury: Insight Gained By Metabolomic Approaches
  56. Biodegradable Self-Assembled Mpeg-Pcl Micelles For Hydrophobic Oridonin Delivery In Vitro
  57. Biosynthesis Of Natural Products. Part 1. Incorporations Of Ent-Kaur-16-Ene And Ent-Kaur-16-En-15-One Into Enmein And Oridonin
  58. Biosynthesis Of Natural Products. Part 4. Biosynthesis Of Enmein And Oridonin From Mono-Or Di-Oxygenated Kaurenoids
  59. Biosynthesis Of The Diterpenes Enmein And Oridonin From Ent-16-Kaurene
  60. Bioynthesis Of Enmein And Oridonin From 15-Oxygenated Kaurenoids And 14-DeoxyOridonin
  61. Caspase Inhibition Augmented Oridonin-Induced Cell Death In Murine Fibrosarcoma L929 By Enhancing Reactive Oxygen Species Generation
  62. Cell Cycle Progression, And Expression Of Nf-Κb In Human Breast Cancer Cells Mcf-7, Mcf-10A, And Mda-Mb-231 By Ponicidin And Oridonin, Diterpenoids From The …
  63. Change Of Bcl-2 Expression And Telomerase During Apoptosis Induced By Oridonin On Human Hepatocelluar Carcinoma Cells
  64. Changes In Mitochondrial And Intracellular Calcium Ions In Process Of Sheec Cells Apoptosis Induced By Oridonin [J]
  65. Characterization And In Vivo Evaluation Of An Inclusion Complex Of Oridonin And 2-Hydroxypropyl-Β-Cyclodextrin
  66. Characterizing The Interaction Between Oridonin And Bovine Serum Albumin By A Hybrid Spectroscopic Approach
  67. Chemical Proteomics Reveals Hsp70 1A As A Target For The Anticancer Diterpene Oridonin In Jurkat Cells
  68. Combined Activity Of Oridonin And Wogonin In Advanced-Stage Ovarian Cancer Cells
  69. Combined Oridonin With Cetuximab Treatment Shows Synergistic Anticancer Effects On Laryngeal Squamous Cell Carcinoma: Involvement Of Inhibition Of Egfr …
  70. Comparasion Of Content Of Oridonin In Rabdosia Rubescens Tea Made In Different Methods
  71. Comparative Studies On Glycerol Monooleate- And Phytantriol-Based Cubosomes Containing Oridonin In Vitro And In Vivo
  72. Composition For The Treatment Of Resistant Cancers Comprising Oridonin
  73. Cosmetic Compositions Comprising Oridonin And New Cosmetic Uses
  74. Cover Picture: Derivation Of Oridonin With Bioreduction‐Responsive Disulfide Bond (Chin. J. Chem. 5/2014)
  75. Crystal Structure Of Oridonin
  76. Cytochrome C Release From Oridonin-Treated Apoptotic A375-S2 Cells Is Dependent On P53 And Extracellular Signal-Regulated Kinase Activation
  77. Delivery Of Oridonin And Methotrexate Via Pegylated Graphene Oxide
  78. Derivation Of Oridonin With Bioreduction‐Responsive Disulfide Bond
  79. Design And Synthesis Of Novel Oridonin Analogues As Potent Anticancer Agents
  80. Design, Synthesis And Antimycobacterial Activity Evaluation Of Natural Oridonin Derivatives
  81. Design, Synthesis And Biological Mechanisms Research On 1, 2, 3-Triazole Derivatives Of Jiyuan Oridonin A
  82. Design, Synthesis, And Biological Evaluation Of Nad (P) H: Quinone Oxidoreductase (Nqo1)-Targeted Oridonin Prodrugs Possessing Indolequinone Moiety For Hypoxia …
  83. Determination Of Oridonin And Ponicidin In The Leaves Of Rabdosia Rubescens
  84. Determination Of Oridonin And Rosemarinic Acid In Rabdosia Rubescens By Hplc
  85. Determination Of Oridonin Content In Rabdosia Rubescens Syrup By Hplc
  86. Determination Of Oridonin In Compound Rabdosia Rubescens Buccal Tablets By Hplc
  87. Determination Of Oridonin In Donglingcao Tablets By Hplc
  88. Determination Of Oridonin In Leaves And Stems Of Blushred Rabdosia By Hplc
  89. Determination Of Oridonin In Mice Liver Following Tail Intravenous Injection Of Oridonin Solid Liposome Nanoparti-Cles By Hplc [J]
  90. Determination Of Oridonin In Rabdosia Rubescens By Tlc-Scanning Method
  91. Determination Of Oridonin In Rabdosia Rubescens By Tlc-Scanning Method [J]
  92. Determination Of Oridonin In Rat Plasma By Reverse-Phase High-Performance Liquid Chromatography
  93. Determination Of Oridonin In The Rabdosia Rubescens Tablets By High Performance Capillary Electropho-Resis [J]
  94. Development And In-Vivo Assessment Of The Bioavailability Of Oridonin Solid Dispersions By The Gas Anti-Solvent Technique
  95. Discovery And Development Of Natural Product Oridonin-Inspired Anticancer Agents
  96. Discovery Of Potent Oridonin Derivatives For The Treatment Of Breast Cancer.
  97. Dna Damage Induced By Oridonin Involves Cell Cycle Arrest At G2/M Phase In Human Mcf-7 Cells
  98. Dose-Response Of Oridonin On Cytochromes P450 Mrna Expression And Activities In Ls174T Cells
  99. Dose-Response Of Oridonin On Hepatic Cytochromes P450 Mrna Expression And Activities In Mice
  100. Downregulation Of Ap‐1 Gene Expression Is An Initial Event In The Oridonin‐Mediated Inhibition Of Colorectal Cancer: Studies In Vitro And In Vivo
  101. Downregulation Of Cdk1 And Cyclinb1 Expression Contributes To Oridonin-Induced Cell Cycle Arrest At G
  102. Downregulation Of Lncrna Afap1-As1 By Oridonin Inhibits The Epithelial-To-Mesenchymal Transition And Proliferation Of Pancreatic Cancer Cells
  103. Downregulation Of Nucleoporin 88 And 214 Induced By Oridonin May Protect Ocim2 Acute Erythroleukemia Cells From Apoptosis Through Regulation Of …
  104. Effect Of Dietary Oridonin Supplementation On Growth Performance, Gut Health, And Immune Response Of Broilers Infected With Salmonella Pullorum
  105. Effect Of Micron Oridonin On Mouse H_ (22) Tumor Cell Apoptosis [J]
  106. Effect Of Oridonin On Apoptosis And Intracellular Reactive Oxygen Species Level In Triple-Negative Breast Cancer Mda-Mb-231 Cells
  107. Effect Of Oridonin On Cytochrome P450 Expression And Activities In Heparg Cell
  108. Effect Of Oridonin, Arabdosia Diterpenoid, On Radiosensitization With Misonidazole
  109. Effect Of Oridonin, Xindongnin A, Ponicidin, Eriocalyxin B On Human Angiogenesis In Vitro
  110. Effect Of Oridonin-Mediated Hallmark Changes On Inflammatory Pathways In Human Pancreatic Cancer (Bxpc-3) Cells
  111. Effect Of Rare-Earth Elements On Callus Growth And Oridonin And Ponicidin In Rabdosia Rubescens [J]
  112. Effective Two-Dimensional Counter-Current Chromatographic Method For Simultaneous Isolation And Purification Of Oridonin And Ponicidin From The Crude Extract Of …
  113. Effects And Mechanisms Of Oridonin In The Treatment Of Acute Respiratory Distress Syndrome Mice
  114. Effects Of Dietary Supplementation With Oridonin On The Growth Performance, Relative Organ Weight, Lymphocyte Proliferation, And Cytokine Concentration In …
  115. Effects Of Light Quality On The Growth And Oridonin Content Of Rabdosia Rubescens Aseptic Seedlings
  116. Effects Of Oridonin Combined With Capecitabine On The Proliferaction Of Mda-Mb-231 Human Breast Cancer Cells
  117. Effects Of Oridonin Nanosuspension On Cell Proliferation And Apoptosis Of Human Prostatic Carcinoma Pc-3 Cell Line
  118. Effects Of Oridonin On Activities Of Rabbit’S Intestinal Smooth Muscle
  119. Effects Of Oridonin On Cell Cycle And Apoptosis Of Multiple Myeloma Cells
  120. Effects Of Oridonin On Growth Performance And Oxidative Stress In Broilers Challenged With Lipopolysaccharide
  121. Effects Of Oridonin On Hepatic Cytochrome P450 Expression And Activities In Pxr-Humanized Mice
  122. Effects Of Oridonin On Human Breast Cancer Bcap-37 Cells And Its Mechanisms
  123. Effects Of Oridonin On Immune Cells, Th1/Th2 Balance And The Expression Of Blys In The Spleens Of Broiler Chickens Challenged With Salmonella Pullorum
  124. Effects Of Oridonin On Nuclear Transcription Factors And Its Target Genes Related Inflammatory Factors In Human Bxpc-3 Cells
  125. Effects Of Oridonin On Proliferation Apoptosis Of Human Multiple Myeloma Cells H929 In Vitro
  126. Effects Of Oridonin On Proliferation Of Ht29 Human Colon Carcinoma Cell Lines Both In Vitro And In Vivo In Mice
  127. Effects Of Oridonin On Proliferation, Cell Cycle And Apoptosis In Human Breast Cancer Cells Mcf-7
  128. Empirical Study Of Oridonin-Induced Gastric Cancer Cells Mkn45 Apoptosis
  129. Enhanced Anti-Fibrogenic Effects Of Novel Oridonin Derivative Cyd0692 In Hepatic Stellate Cells
  130. Enhanced Effects Of Novel Oridonin Analog Cyd0682 For Hepatic Fibrosis
  131. Enhancement Of The Effects Of Gemcitabine Against Pancreatic Cancer By Oridonin Via The Mitochondrial Caspase-Dependent Signaling Pathway
  132. Enmein-Type Diterpenoid Analogs From Natural Kaurene-Type Oridonin: Synthesis And Their Antitumor Biological Evaluation
  133. Er Stress And Ask1-Jnk Activation Contribute To Oridonin-Induced Apoptosis And Growth Inhibition In Cultured Human Hepatoblastoma Huh-6 Cells
  134. Experimental Research On The Mechanisms Of Human Multiple Myeloma Lp-1 Cell Apoptosis Induced By Oridonin
  135. Experimental Study On Anti-Pancreatic Cancer Effect Of Oridonin
  136. Exploration On Induction Of Breast Cancer Bcap37 Apoptosis By Oridonin [J]
  137. Expression Of P63 And Unc5D During Oridonin-Induced Apoptosis In Bladder Cancer Cell Line
  138. Extraction And Purification Method For Oridonin Derived From Rabdosia Rubbescens
  139. Fas/Fasl Signaling Allows Extracelluar-Signal Regulated Kinase To Regulate Cytochrome C Release In Oridonin-Induced Apoptotic U937 Cells
  140. Fibroblast Growth Factor-2 Suppresses Oridonin-Induced L929 Apoptosis Through Extracellular Signal-Regulated Kinase-Dependent And Phosphatidylinositol 3-Kinase …
  141. First Synthesis Of An Oridonin‐Conjugated Iridium (Iii) Complex For The Intracellular Tracking Of Nf‐Κb In Living Cells
  142. Formulation Of Nanocrystalline Oridonin Bioadhesive Tablets And Measurement In Vitro [J]
  143. Freeze-Drying Of Oridonin-Loaded Solid Lipid Nanoparticles (Ori-Sln)
  144. Galactose-Decorated Ph-Responsive Nanogels For Hepatoma-Targeted Delivery Of Oridonin
  145. Galactosylated Bovine Serum Albumin Nanoparticles For Parenteral Delivery Of Oridonin: Tissue Distribution And Pharmacokinetic Studies
  146. Galactosylated Chitosan Nanoparticles For Hepatocyte-Targeted Delivery Of Oridonin
  147. Ge11 Peptide Conjugated Selenium Nanoparticles For Egfr Targeted Oridonin Delivery To Achieve Enhanced Anticancer Efficacy By Inhibiting Egfr-Mediated Pi3K/Akt …
  148. Genomic And In Vivo Evidence Of Synergy Of A Herbal Extract Compared To Its Most Active Ingredient: Rabdosia Rubescens Vs. Oridonin
  149. Geridonin, A Novel Derivative Of Oridonin, Inhibits Proliferation Of Mgc 803 Cells Both In Vitro And In Vivo Through Elevating The Intracellular Ros
  150. Growth Inhibition And Induction Of Apoptosis In Mcf-7 Breast Cancer Cells By Oridonin Nanosuspension
  151. Homoharringtonine Synergy With Oridonin In Treatment Of T (8; 21) Acute Myeloid Leukemia
  152. Hplc Determination Of Content And Entrapment Efficiency Of Oridonin Nanostructured Lipid Carriers
  153. Hplc Determination Of Content And Entrapment Efficiency Of Oridonin Nanostructured Lipid Carriers.
  154. Hplc In Quantitative Determination Of Oridonin And Ponicidin In The Rabdosia Rubescens
  155. Hydrogen Sulfide Releasing Oridonin Derivatives Induce Apoptosis Through Extrinsic And Intrinsic Pathways
  156. Hydroxyl Radical (· Oh) Played A Pivotal Role In Oridonin-Induced Apoptosis And Autophagy In Human Epidermoid Carcinoma A431 Cells
  157. Identification And Comparative Oridonin Metabolism In Different Species Liver Microsomes By Using Uplc-Triple-Tof-Ms/Ms And Pca
  158. Identification Of Metabolites Of Oridonin In Rats With A Single Run On Uplc-Triple-Tof-Ms/Ms System Based On Multiple Mass Defect Filter Data Acquisition And Multiple …
  159. In Vitro And In Vivo Antitumor Activity Of Oridonin Nanosuspension
  160. In Vitro And In Vivo Evaluation Of Oridonin-Loaded Long Circulating Nanostructured Lipid Carriers
  161. In Vitro Cytotoxicity Studies On Galactosylated Chitosan Nanoparticles For The Delivery Of Oridonin To Liver
  162. In Vitro Inhibitory Effect Of Oridonin On Primary Acute Leukeamic Cells
  163. In Vivo Studies On The Oridonin-Loaded Nanostructured Lipid Carriers
  164. Inactivation Of Ras And Changes Of Mitochondrial Membrane Potential Contribute To Oridonin-Induced Autophagy In A431 Cells
  165. Induction Of Apoptosis And G_2/M Cell Cycle Arrest By Oridonin On Human Pancreatic Cancer Panc-1 Cells [J]
  166. Induction Of G2/M Phase Arrest And Apoptosis By Oridonin In Human Laryngeal Carcinoma Cells
  167. Induction Of Human Cyp3A4 By Huperzine A, Ligustrazine And Oridonin Through Pregnane X Receptor-Mediated Pathways
  168. Influence Factors Of Oridonin Extracted With Supercritical Co_2
  169. Influence Of Oridonin Combined With Melphalan On Proliferation And Apoptosis Of Human Myeloma Rpmi8226 Cells
  170. Influence Of Oridonin On The Icilling Acitivity Of Nk-92 Mi Cells Targeting Cell Thp1 And Its Mechanism
  171. Influence Of Verapamil On The Pharmacokinetics Of Oridonin In Rats
  172. Inhalable Oridonin-Loaded Poly (Lactic-Co-Glycolic) Acid Large Porous Microparticles For In Situ Treatment Of Primary Non-Small Cell Lung Cancer
  173. Inhibiting Effects Of Oridonin On Human Nasopharyngeal Cancer Line Cne 2 In Vitro [J]
  174. Inhibition Effect And Mechanism Of Oridonin On Biu-87 Cells [J]
  175. Inhibition Of Autophagy Enhances Apoptosis Involved With Intracellular Ros Generation In Multiple Myeloma Cells Exposed To Oridonin
  176. Inhibition Of Caspase-9 By Oridonin, A Diterpenoid Isolated From Rabdosia Rubescens, Augments Apoptosis In Human Laryngeal Cancer Cells
  177. Inhibition Of C‐M Et Promoted Apoptosis, Autophagy And Loss Of The Mitochondrial Transmembrane Potential In Oridonin‐Induced A 549 Lung Cancer Cells
  178. Inhibition Of Egfr Signaling Augments Oridonin-Induced Apoptosis In Human Laryngeal Cancer Cells Via Enhancing Oxidative Stress Coincident With Activation Of Both …
  179. Inhibition Of Mir-17 And Mir-20A By Oridonin Triggers Apoptosis And Reverses Chemoresistance By Derepressing Bim-S
  180. Inhibition Of Nuclear Factor Κb Transcription Activity Drives A Synergistic Effect Of Cisplatin And Oridonin On Hepg2 Human Hepatocellular Carcinoma Cells
  181. Inhibition Of The Invasion Of Human Breast Cancer Cells By Oridonin And The Underlying Mechanims
  182. Inhibitory Effect And Mechanism Of Oridonin On Raji Cells Proliferation
  183. Inhibitory Effect Of Oridonin Injection On Heterotransplanted Gastric Adenocarcinoma In Nude Mice And Its Mechanism
  184. Inhibitory Effect Of Oridonin On Bladder Cancer T24 Cells And Its Mechanism
  185. Inhibitory Effect Of Oridonin On Leukemic Nb4 Cells And Its Mechanism
  186. Inhibitory Effect Of Oridonin On Proliferation Of H22 Transplanted Tumor And Its Mechanism Analysis
  187. Inhibitory Effect Of Oridonin On Proliferation Of Rpmi8226 Cells And The Possible Underlying Mechanism
  188. Inhibitory Effect Of Oridonin On The Proliferation Of Nb4 Cells And Its Mechanism
  189. Inhibitory Effects Of Novel Oridonin Analog Cyd0617-2 On Hepatic Stellate Cell Activation Through Nf-Κb And Stat3 Pathways
  190. Interaction Of Oridonin With Human Serum Albumin By Isothermal Titration Calorimetry And Spectroscopic Techniques
  191. Interruption Of Hepatocyte Growth Factor Signaling Augmented Oridonin-Induced Death In Human Non-Small Cell Lung Cancer A549 Cells Via C-Met-Nuclear Factor-Κb …
  192. Intracellular Glutathione Depletion By Oridonin Leads To Apoptosis In Hepatic Stellate Cells
  193. Investigation Of Metal-Organic Framework-5 (Mof-5) As An Antitumor Drug Oridonin Sustained Release Carrier
  194. Investigation Of The Anti‑Asthmatic Activity Of Oridonin On A Mouse Model Of Asthma
  195. Investigation On Factors Affecting Entrapment Efficiency Of Oridonin-Loaded Liposome [J]
  196. Involvement Of Glutathione Depletion In Selective Cytotoxicity Of Oridonin To P53-Mutant Esophageal Squamous Carcinoma Cells
  197. Involvement Of Pkc Signal Pathways In Oridonin-Induced Autophagy In Hela Cells: A Protective Mechanism Against Apoptosis
  198. Isolation And Purification Of Oridonin From Rabdosia Rubescens Using Upright Counter‐Current Chromatography
  199. Isolation And Purification Of Oridonin From The Whole Plant Of Isodon Rubescens By High-Speed Counter-Current Chromatography
  200. Iuduction Of Apoptosis In Hl-60 Cells By Oridonin [J]
  201. Mechanism Concerning Antitumor Effect Of Oridonin On Multiple Myeloma Cell Line U266
  202. Mechanism Of Downregulation Of Apoptosis By Autophagy Induced By Oridonin In Hela Cells
  203. Metastasis-Inhibiting Effect Of Oridonin On Mg-63 Cells And Its Mechanisms
  204. Method For Extracting Oridonin From Rabdosia Rubescens And Purifying Oridonin
  205. Microphotometric And Autoradiographic Studies Of Cytokinetic Effects Of Oridonin On L_ (1210) And S_ (180) Cells
  206. Mitochondrial Ros Contribute To Oridonin-Induced Hepg2 Apoptosis Through Parp Activation
  207. Molecular Insight In The Multifunctional Effects Of Oridonin
  208. Molecular Mechanism Of Oridonin In Inhibiting Proliferation And Inducing Apoptosis Of Osteosarcoma Cell Mg-63
  209. Molecular Mechanisms Of Apoptosis And Autophagy Elicited By Combined Treatment With Oridonin And Cetuximab In Laryngeal Squamous Cell Carcinoma
  210. Molecular Mechanisms Of Oridonin-Induced Apoptosis And Autophagy In Murine Fibrosarcoma L929 Cells
  211. Molecule Mechanisms Of Oridonin On Tumors Chemoprevention And Therapy
  212. Mucosal Transfer Of Wheat Germ Agglutinin Modified Lipid–Polymer Hybrid Nanoparticles For Oral Delivery Of Oridonin
  213. Multiple-Modulation Effects Of Oridonin On The Production Of Proinflammatory Cytokines And Neurotrophic Factors In Lps-Activated Microglia
  214. Nanostructured Lipid Carriers Used For Oral Delivery Of Oridonin: An Effect Of Ligand Modification On Absorption
  215. Nanosuspensions Containing Oridonin/Hp-Β-Cyclodextrin Inclusion Complexes For Oral Bioavailability Enhancement Via Improved Dissolution And Permeability
  216. Natural Compound Oridonin Inhibits Endotoxin-Induced Inflammatory Response Of Activated Hepatic Stellate Cells
  217. Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis By Promoting Anti-Inflammatory Macrophages Through Blocking Notch Pathway.
  218. Natural Product-Inspired Drug Discovery: Chemistry And Biology Of Oridonin Analogs With Unique Scaffolds And Enhanced Anticancer Profiles.
  219. New Method For Preparing Oridonin By Column Chromatography
  220. New Method For Preparing Oridonin By Supercritical Co~ 2 Fluid Extraction And Column Chromatography
  221. Nf-Κb Facilitates Oridonin-Induced Apoptosis And Autophagy In Ht1080 Cells Through A P53-Mediated Pathway
  222. Nitric Oxide Augments Oridonin-Induced Efferocytosis By Human Histocytic Lymphoma U937 Cells Via Autophagy And The Nf-Κb-Cox-2-Il-1Β Pathway
  223. Nmr Spectra And Structures Of Oridonin Derivatives Complexes With Β‐Cyclodextrin
  224. Novel Acetal And Halogen Oridonin Analogues Potently Induce Apoptosis In Prostate Cancer Cell Lines Via Induction Of P53/P73 And Puma Expression
  225. Novel Anticancer Oridonin Derivatives Possessing A Diazen-1-Ium-1, 2-Diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation And Nitric Oxide …
  226. Novel Galactosylated Biodegradable Nanoparticles For Hepatocyte-Delivery Of Oridonin
  227. Novel Hybrids Of Natural Oridonin-Bearing Nitrogen Mustards As Potential Anticancer Drug Candidates
  228. Novel Nitrogen-Enriched Oridonin Analogues With Thiazole-Fused A-Ring: Protecting Group-Free Synthesis, Enhanced Anticancer Profile, And Improved Aqueous Solubility
  229. Of Longikaurin A And Longikaurin B, New Biologically Active Diterpenoids From Rabdosia Longituba And Chemical Conversion Of Oridonin Into Dihydrolongikaurin A
  230. On The Crystal Structure Of Oridonin
  231. Optimization And Evaluation Of Oridonin-Loaded Soluplus®-Pluronic P105 Mixed Micelles For Oral Administration
  232. Optimization And In Situ Intestinal Absorption Of Self-Microemulsifying Drug Delivery System Of Oridonin
  233. Optimization Of The Formulation And Process Of Biotinylated Oridonin Liposomes
  234. Optimized Preparation Of Oridonin-Loaded Nanoparticles By Central Composite Design And Response Surface Method [J]
  235. Oridonin Alleviates Visceral Hyperalgesia In A Rat Model Of Postinflammatory Irritable Bowel Syndrome: Role Of Colonic Enterochromaffin Cell And Serotonin Availability
  236. Oridonin Alters The Expression Profiles Of Micrornas In Bxpc-3 Human Pancreatic Cancer Cells
  237. Oridonin Ameliorates Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury In Mice Via Inhibition Of Apoptosis
  238. Oridonin Ameliorates Lipopolysaccharide-Induced Endometritis In Mice Via Inhibition Of The Tlr-4/Nf-Κbpathway
  239. Oridonin Ameliorates Lupus-Like Symptoms Of Mrllpr/Lpr Mice By Inhibition Of B-Cell Activating Factor (Baff)
  240. Oridonin Ameliorates Neuropathological Changes And Behavioural Deficits In A Mouse Model Of Cerebral Amyloidosis
  241. Oridonin Analogs, Compositions, And Methods Related Thereto
  242. Oridonin Attenuates Aβ1–42-Induced Neuroinflammation And Inhibits Nf-Κb Pathway
  243. Oridonin Attenuates Carrageenan-Induced Pleurisy Via Activation Of The Keap-1/Nrf2 Pathway And Inhibition Of The Txnip/Nlrp3 And Nf-Κb Pathway In Mice
  244. Oridonin Attenuates Synaptic Loss And Cognitive Deficits In An Aβ1–42-Induced Mouse Model Of Alzheimer’S Disease
  245. Oridonin Attenuates The Release Of Pro-Inflammatory Cytokines In Lipopolysaccharide-Induced Raw264. 7 Cells And Acute Lung Injury
  246. Oridonin Confers Protection Against Arsenic-Induced Toxicity Through Activation Of The Nrf2-Mediated Defensive Response
  247. Oridonin Derivative Ameliorates Experimental Colitis By Inhibiting Activated T‐Cells And Translocation Of Nuclear Factor‐Kappa B
  248. Oridonin Derivatives As Potential Anticancer Drug Candidates Triggering Apoptosis Through Mitochondrial Pathway In The Liver Cancer Cells
  249. Oridonin Effectively Reverses Cisplatin Drug Resistance In Human Ovarian Cancer Cells Via Induction Of Cell Apoptosis And Inhibition Of Matrix Metalloproteinase …
  250. Oridonin Effectively Reverses The Drug Resistance Of Cisplatin Involving Induction Of Cell Apoptosis And Inhibition Of Mmp Expression In Human Acute Myeloid …
  251. Oridonin Elevates Sensitivity Of Ovarian Carcinoma Cells To Cisplatin Via Suppressing Cisplatin-Mediated Autophagy
  252. Oridonin Enhances Antitumor Activity Of Gemcitabine In Pancreatic Cancer Through Mapk-P38 Signaling Pathway
  253. Oridonin Enhances In Vitro Anticancer Effects Of Lentinan In Smmc‑7721 Human Hepatoma Cells Through Apoptotic Genes
  254. Oridonin Enhances Phagocytosis Of Uv-Irradiated Apoptotic U937 Cells
  255. Oridonin Enhances Radiation-Induced Cell Death By Promoting Dna Damage In Non-Small Cell Lung Cancer Cells
  256. Oridonin Enhances The Anticancer Activity Of Nvp-Bez235 Against Neuroblastoma Cells In Vitro And In Vivo Through Autophagy
  257. Oridonin Enhances The Cytotoxicity Of 5-Fu In Renal Carcinoma Cells By Inducting Necroptotic Death
  258. Oridonin Enhances The Radiosensitivity Of Lung Cancer Cells By Upregulating Bax And Downregulating Bcl‑2
  259. Oridonin Enhances Trail-Induced Apoptosis Through Galnt14-Mediated Dr5 Glycosylation
  260. Oridonin Enhances Γ‑Globin Expression In Erythroid Precursors From Patients With Β‑Thalassemia Via Activation Of P38 Mapk Signaling
  261. Oridonin Exerts Anticancer Effect On Osteosarcoma By Activating Ppar-Γ And Inhibiting Nrf2 Pathway
  262. Oridonin Exerts Protective Effects Against Hydrogen Peroxide‑Induced Damage By Altering Microrna Expression Profiles In Human Dermal Fibroblasts
  263. Oridonin Functionalized Selenium Nanoparticles And Method Of Preparation Thereof
  264. Oridonin In Combination With Imatinib Exerts Synergetic Anti-Leukemia Effect In Ph+ Acute Lymphoblastic Leukemia Cells In Vitro By Inhibiting Activation Of Lyn/Mtor …
  265. Oridonin Increases Anticancer Effects Of Lentinan In Hepg2 Human Hepatoblastoma Cells
  266. Oridonin Induced A375-S2 Cell Apoptosis Through Caspase-3 Pathway After Altered Expression Of Bax/Bcl-Xl
  267. Oridonin Induced A375-S2 Cell Apoptosis Via Bax-Regulated Caspase Pathway Activation, Dependent On The Cytochrome C/Caspase-9 Apoptosome
  268. Oridonin Induced Apoptosis Through Akt And Mapks Signaling Pathways In Human Osteosarcoma Cells
  269. Oridonin Induced Autophagy In Human Cervical Carcinoma Hela Cells Through Ras, Jnk, And P38 Regulation
  270. Oridonin Induced Hepg2 Cell Death Partially Through Tnfα Signal Pathway [J]
  271. Oridonin Induced Mda-Mb-231 Cell Apoptosis Through The Action Of Caspase Pathway
  272. Oridonin Induced The Apoptosis Of Pc-3 Cells And Its Mechanism.
  273. Oridonin Induced The Hepg_2 Cells Apoptosis By The Activation Of The Atr Pathway
  274. Oridonin Induced U937 Cell Apoptosis Through Erk Pathway
  275. Oridonin Induces A Caspase-Independent But Mitochondria-And Mapk-Dependent Cell Death In The Murine Fibrosarcoma Cell Line L929
  276. Oridonin Induces Apoptosis And Autophagy In Murine Fibrosarcoma L929 Cells Partly Via No-Erk-P53 Positive-Feedback Loop Signaling Pathway
  277. Oridonin Induces Apoptosis And Cell Cycle Arrest In Activated Hepatic Stellate Cells And Reduces Proliferation And Extracellular Matrix Protein Production
  278. Oridonin Induces Apoptosis And Cell Cycle Arrest Of Gallbladder Cancer Cells Via The Mitochondrial Pathway
  279. Oridonin Induces Apoptosis And Reverses Drug Resistance In Cisplatin Resistant Human Gastric Cancer Cells
  280. Oridonin Induces Apoptosis And Senescence By Increasing Hydrogen Peroxide And Glutathione Depletion In Colorectal Cancer Cells
  281. Oridonin Induces Apoptosis And Senescence In Colorectal Cancer Cells By Increasing Histone Hyperacetylation And Regulation Of P16, P21, P27 And C-Myc
  282. Oridonin Induces Apoptosis And Senescence Of Colorectal Cancer Sw1116 Cells In Vitro And In Vivo [J]
  283. Oridonin Induces Apoptosis In Gastric Cancer Through Apaf-1, Cytochrome C And Caspase-3 Signaling Pathway
  284. Oridonin Induces Apoptosis In Hgc‑27 Cells By Activating The Jnk Signaling Pathway
  285. Oridonin Induces Apoptosis In Human Nasopharyngeal Carcinoma Cells Involving Ros Generation
  286. Oridonin Induces Apoptosis In Human Oral Cancer Cells Via Phosphorylation Of Histone H2 Ax
  287. Oridonin Induces Apoptosis In Oral Squamous Cell Carcinoma Probably Through The Generation Of Reactive Oxygen Species And The P38/Jnk Mapk Pathway
  288. Oridonin Induces Apoptosis In Sw1990 Pancreatic Cancer Cells Via P53-And Caspase-Dependent Induction Of P38 Mapk
  289. Oridonin Induces Apoptosis In Uveal Melanoma Cells By Upregulation Of Bim And Downregulation Of Fatty Acid Synthase
  290. Oridonin Induces Apoptosis Of Hela Cells Via Altering Expression Of Bcl-2/Bax And Activating Caspase-3/Icad Pathway.
  291. Oridonin Induces Apoptosis Of Hepg2 Cells Via Downregulating Stat3-HkⅡ Pathway
  292. Oridonin Induces Apoptosis Of Human Multiple Myeloma Arh-77 Cells And Its Possible Mechanism [J]
  293. Oridonin Induces Apoptosis Of Myeloma Cells By Inducing C-Myc Degradation Via Nuclear Accumulation Of Fbxw7Α
  294. Oridonin Induces Apoptosis Through The Mitochondrial Pathway In Human Gastric Cancer Sgc-7901 Cells
  295. Oridonin Induces Apoptosis Via Pi3K/Akt Pathway In Cervical Carcinoma Hela Cell Line1
  296. Oridonin Induces Apoptosis, Inhibits Migration And Invasion On Highly-Metastatic Human Breast Cancer Cells
  297. Oridonin Induces Autophagy Via Inhibition Of Glucose Metabolism In P53-Mutated Colorectal Cancer Cells
  298. Oridonin Induces G2/M Arrest And Apoptosis Via Activating Erk–P53 Apoptotic Pathway And Inhibiting Ptk–Ras–Raf–Jnk Survival Pathway In Murine Fibrosarcoma …
  299. Oridonin Induces G2/M Cell Cycle Arrest And Apoptosis In Human Oral Squamous Cell Carcinoma
  300. Oridonin Induces G2/M Cell Cycle Arrest And Apoptosis Through Mapk And P53 Signaling Pathways In Hepg2 Cells
  301. Oridonin Induces G2/M Cell Cycle Arrest And Apoptosis Via The Pi3K/Akt Signaling Pathway In Hormone-Independent Prostate Cancer Cells
  302. Oridonin Induces Growth Inhibition And Apoptosis In Human Gastric Carcinoma Cells By Enhancement Of P53 Expression And Function
  303. Oridonin Induces Growth Inhibition And Apoptosis Of A Variety Of Human Cancer Cells
  304. Oridonin Induces Human Epidermoid Carcinoma A431 Cell Apoptosis Through Tyrosine Kinase And Mitochondrial Pathway
  305. Oridonin Induces Human Melanoma A375-S2 Cell Death Partially Through Inhibiting Insulin-Like Growth Factor 1 Receptor Signaling
  306. Oridonin Induces Mdm2‐P60 To Promote P53‐Mediated Apoptosis And Cell Cycle Arrest In Neuroblastoma
  307. Oridonin Induces Npm Mutant Protein Translocation And Apoptosis In Npm1C+ Acute Myeloid Leukemia Cells In Vitro
  308. Oridonin Induces The Apoptosis Of Metastatic Hepatocellular Carcinoma Cells Via A Mitochondrial Pathway
  309. Oridonin Inhibited The Growth Of Bgc823 Cells And The Expression Of Mmp-2 Mmp-9 [J]
  310. Oridonin Inhibited The Tyrosine Kinase Activity And Induced Apoptosis In Human Epidermoid Carcinoma A431 Cells
  311. Oridonin Inhibition And Mir‑200B‑3P/Zeb1 Axis In Human Pancreatic Cancer
  312. Oridonin Inhibits Aberrant Akt Activation In Breast Cancer
  313. Oridonin Inhibits Breast Cancer Growth And Metastasis Through Blocking The Notch Signaling
  314. Oridonin Inhibits Burn Injury-Induced Activation And Inflammatory Signaling Of Hepatic Stellate Cells
  315. Oridonin Inhibits Bxpc-3 Cell Growth Through Cell Apoptosis
  316. Oridonin Inhibits Cell Growth By Induction Of Apoptosis On Human Hepatocelluar Carcinoma Bel-7402 Cells
  317. Oridonin Inhibits Cell Proliferation And Induces Apoptosis In Rheumatoid Arthritis Fibroblast-Like Synoviocytes
  318. Oridonin Inhibits Gefitinib-Resistant Lung Cancer Cells By Suppressing Egfr/Erk/Mmp-12 And Cip2A/Akt Signaling Pathways
  319. Oridonin Inhibits Growth And Induces Apoptosis Of Human Neurocytoma Cells Via The Wnt/Β‑Catenin Pathway
  320. Oridonin Inhibits Hepatic Stellate Cell Proliferation And Fibrogenesis
  321. Oridonin Inhibits Il-1Β-Induced Inflammation In Human Osteoarthritis Chondrocytes By Activating Ppar-Γ
  322. Oridonin Inhibits Lps-Induced Inflammation In Human Gingival Fibroblasts By Activating Pparγ
  323. Oridonin Inhibits Metastasis Of Human Ovarian Cancer Cells By Suppressing The Mtor Pathway
  324. Oridonin Inhibits Migration, Invasion, Adhesion And Tgf‑Β1‑Induced Epithelial‑Mesenchymal Transition Of Melanoma Cells By Inhibiting The Activity Of Pi3K/Akt …
  325. Oridonin Inhibits Myofibroblast Differentiation And Bleomycin-Induced Pulmonary Fibrosis By Regulating Transforming Growth Factor Β (Tgfβ)/Smad Pathway
  326. Oridonin Inhibits Oral Cancer Growth And Pi3K/Akt Signaling Pathway
  327. Oridonin Inhibits Pancreatic Cancer Cell Migration And Epithelial-Mesenchymal Transition By Suppressing Wnt/Β-Catenin Signaling Pathway
  328. Oridonin Inhibits Proliferation Of Jurkat Cells Via The Down-Regulation Of Brg1
  329. Oridonin Inhibits The Proliferation Of Human Colon Cancer Cells By Upregulating Bmp7 To Activate P38 Mapk
  330. Oridonin Inhibits The Proliferation Of Human Osteosarcoma Cells By Suppressing Wnt/Β-Catenin Signaling
  331. Oridonin Inhibits The Proliferation, Migration And Invasion Of Human Osteosarcoma Cells Via Suppression Of Matrix Metalloproteinase Expression And Stat3 …
  332. Oridonin Inhibits Tumor Growth And Metastasis Through Anti-Angiogenesis By Blocking The Notch Signaling
  333. Oridonin Inhibits Vascular Inflammation By Blocking Nf-Κb And Mapk Activation
  334. Oridonin Inhibits Vegf‑A‑Associated Angiogenesis And Epithelial‑Mesenchymal Transition Of Breast Cancer In Vitro And In Vivo
  335. Oridonin Is A Covalent Nlrp3 Inhibitor With Strong Anti-Inflammasome Activity
  336. Oridonin Loaded Solid Lipid Nanoparticles Enhanced Antitumor Activity In Mcf-7 Cells
  337. Oridonin Nanosuspension Enhances Anti-Tumor Efficacy In Smmc-7721 Cells And H22 Tumor Bearing Mice
  338. Oridonin Nanosuspension Was More Effective Than Free Oridonin On G2/M Cell Cycle Arrest And Apoptosis In The Human Pancreatic Cancer Panc-1 Cell Line
  339. Oridonin Overcomes The Gemcitabine Resistant Panc-1/Gem Cells By Regulating Gst Pi And Lrp/1 Erk/Jnk Signalling
  340. Oridonin Phosphate-Induced Autophagy Effectively Enhances Cell Apoptosis Of Human Breast Cancer Cells
  341. Oridonin Prevents Epithelial-Mesenchymal Transition And Tgf-Β1-Induced Epithelial-Mesenchymal Transition By Inhibiting Tgf-Β1/Smad2/3 In Osteosarcoma
  342. Oridonin Prevents Insulin Resistance–Mediated Cognitive Disorder Through Pten/Akt Pathway And Autophagy In Minimal Hepatic Encephalopathy
  343. Oridonin Promotes Cd4+/Cd25+ Treg Differentiation, Modulates Th1/Th2 Balance And Induces Ho-1 In Rat Splenic Lymphocytes
  344. Oridonin Promotes G2/M Arrest In A549 Cells By Facilitating Atm Activation
  345. Oridonin Protects Against Cardiac Hypertrophy By Promoting P21-Related Autophagy
  346. Oridonin Protects Against The Inflammatory Response In Diabetic Nephropathy By Inhibiting The Tlr4/P38-Mapk And Tlr4/Nf-Κb Signaling Pathways
  347. Oridonin Protects Hacat Keratinocytes Against Hydrogen Peroxide-Induced Oxidative Stress By Altering Microrna Expression
  348. Oridonin Protects Lps-Induced Acute Lung Injury By Modulating Nrf2-Mediated Oxidative Stress And Nrf2-Independent Nlrp3 And Nf-Κb Pathways
  349. Oridonin Protects The Lung Against Hyperoxia-Induced Injury In A Mouse Model.
  350. Oridonin Relieves Hypoxia-Evoked Apoptosis And Autophagy Via Modulating Microrna-214 In H9C2 Cells
  351. Oridonin Ring A-Based Diverse Constructions Of Enone Functionality: Identification Of Novel Dienone Analogues Effective For Highly Aggressive Breast Cancer By Inducing …
  352. Oridonin Sensitizes Cisplatin-Induced Apoptosis Via Ampk/Akt/Mtor-Dependent Autophagosome Accumulation In A549 Cells
  353. Oridonin Stabilizes Retinoic Acid Receptor Alpha Through Ros-Activated Nf-Κb Signaling
  354. Oridonin Suppress Cell Migration Via Regulation Of Nonmuscle Myosin Iia
  355. Oridonin Suppresses Autophagy And Survival In Rheumatoid Arthritis Fibroblast-Like Synoviocytes
  356. Oridonin Suppresses Transplant Rejection By Depleting T Cells From The Periphery
  357. Oridonin Synergistically Enhances Jq1-Triggered Apoptosis In Hepatocellular Cancer Cells Through Mitochondrial Pathway
  358. Oridonin Synergistically Enhances The Anti-Tumor Efficacy Of Doxorubicin Against Aggressive Breast Cancer Via Pro-Apoptotic And Anti-Angiogenic Effects
  359. Oridonin Synergizes With Nutlin-3 In Osteosarcoma Cells By Modulating The Levels Of Multiple Bcl-2 Family Proteins
  360. Oridonin Targets Multiple Drug-Resistant Tumor Cells As Determined By In Silico And In Vitro Analyses
  361. Oridonin Triggers Apoptosis In Colorectal Carcinoma Cells And Suppression Of Microrna-32 Expression Augments Oridonin-Mediated Apoptotic Effects
  362. Oridonin Triggers Chaperon-Mediated Proteasomal Degradation Of Bcr-Abl In Leukemia
  363. Oridonin Upregulates All-Trans Retinoic Acid Receptor Alpha And Induces Differentiation Of Nb4 Cells Though Nf-Kb Pathway
  364. Oridonin Up-Regulates Expression Of P21 And Induces Autophagy And Apoptosis In Human Prostate Cancer Cells
  365. Oridonin Upregulates Pten Gene Expression And Induces Apoptosis Of Hepg2 Cells
  366. Oridonin Upregulates Pten Through Activating P38 Mapk And Inhibits Proliferation In Human Colon Cancer Cells
  367. Oridonin, A Diterpenoid Extracted From Medicinal Herbs, Targets Aml1-Eto Fusion Protein And Shows Potent Antitumor Activity With Low Adverse Effects On T (8; 21) …
  368. Oridonin, A Diterpenoid Purified From Rabdosia Rubescens, Inhibits The Proliferation Of Cells From Lymphoid Malignancies In Association With Blockade Of The Nf-Κb …
  369. Oridonin, A Natural Diterpenoid, Protected Ngf-Differentiated Pc12 Cells Against Mpp+-And Kainic Acid-Induced Injury
  370. Oridonin, A New Diterpenoid From Isodon Species
  371. Oridonin, A Novel Lysine Acetyltransferases Inhibitor, Inhibits Proliferation And Induces Apoptosis In Gastric Cancer Cells Through P53-And Caspase-3-Mediated …
  372. Oridonin, A Promising Antitumor Natural Product In The Chemotherapy Of Hematological Malignancies
  373. Oridonin, A Promising Ent-Kaurane Diterpenoid Lead Compound
  374. Oridonin, An Ent-Kaurane Diterpenoid, Shows Antileukemic Effect And Enhances The Effect Of Indarubicin On Human T-Cell Leukemia Cell Line
  375. Oridonin: A Promising Anticancer Drug From China
  376. Oridonin: A Small Molecule Inhibitor Of Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) Isolated From Traditional Chinese Medicine
  377. Oridonin: An Active Diterpenoid Targeting Cell Cycle Arrest, Apoptotic And Autophagic Pathways For Cancer Therapeutics
  378. Oridonin: Targeting Programmed Cell Death Pathways As An Anti‐Tumour Agent
  379. Oridonin-Generated Cleavage Fragment Of Aml1-Eto Inhibits Its Oligomerization And Oncogenic Function Leading To Differentiation And Apoptosis Of Leukemic Cells …
  380. Oridonin-Induced A375-S2 Cell Apoptosis Through Mitochondrial Pathway
  381. Oridonin-Induced A431 Cell Apoptosis Partially Through Blockage Of The Ras/Raf/Erk Signal Pathway
  382. Oridonin-Induced Apoptosis In Leukemia K562 Cells And Its Mechanism.
  383. Oridonin-Induced Apoptosis In Sw620 Human Colorectal Adenocarcinoma Cells
  384. Oridonin-Induced Apoptosis Of Jurkat Cells And Its Mechanism
  385. Oridonin‐Induced Mitochondria‐Dependent Apoptosis In Esophageal Cancer Cells By Inhibiting Pi3K/Akt/Mtor And Ras/Raf Pathways
  386. Oridonin-Loaded And Gpc1-Targeted Gold Nanoparticles For Multimodal Imaging And Therapy In Pancreatic Cancer
  387. Oridonin-Loaded Poly (Ε-Caprolactone)–Poly (Ethylene Oxide)–Poly (Ε-Caprolactone) Copolymer Nanoparticles: Preparation, Characterization, And Antitumor Activity On …
  388. Orthogonal Experimental Research On Decoction Technology Of Oridonin [J]
  389. Overcoming Synthetic Challenges Of Oridonin A-Ring Structural Diversification: Regio-And Stereoselective Installation Of Azides And 1, 2, 3-Triazoles At The C-1, C-2, Or C-3 …
  390. P53-Mediated Cell Cycle Arrest And Apoptosis Through A Caspase-3-Independent, But Caspase-9-Dependent Pathway In Oridonin-Treated Mcf-7 Human Breast Cancer …
  391. Pharmacokinetic Behaviors And Oral Bioavailability Of Oridonin In Rat Plasma
  392. Pharmacokinetic Behaviors And Oral Bioavailability Of Oridonin In Rat Plasma1
  393. Pharmacokinetics Of Injectable Beta-Cyclodextrin-Oridonin Inclusion Complex, A Novel Formulation Of Oridonin In Wistar Rats
  394. Phytotherapeutics Oridonin And Ponicidin Show Additive Effects Combined With Irradiation In Pancreatic Cancer In Vitro
  395. Ponicidin And Oridonin Are Responsible For The Antiangiogenic Activity Of Rabdosia Rubescens, A Constituent Of The Herbal Supplement Pc Spes
  396. Preliminary Safety Assessment Of Oridonin In Zebrafish
  397. Preliminary Study On The Mechanism Of Oridonin-Induced Apoptosis In Human Squamous Cell Oesophageal Carcinoma Cell Line Ec9706
  398. Preparation And Anti-Tumor Effect Of Oridonin Loaded Cholesteryl Formate-Graft Chitosan Copolymer Nano-Micelles
  399. Preparation And Characteristics Of Oridonin-Loaded Nanostructured Lipid Carriers As A Controlled-Release Delivery System
  400. Preparation And Characterization Of An Oridonin Nanosuspension For Solubility And Dissolution Velocity Enhancement
  401. Preparation And Characterization Of Galactosylated Bovine Serum Albumin Nanoparticles For Liver-Targeted Delivery Of Oridonin
  402. Preparation And Characterization Of Oridonin Phospholipid Complex
  403. Preparation And Characterization Of Oridonin Submicron Emulsions
  404. Preparation And Characterization Of Oridonin-Loaded Block Copolymer Micelles [J]
  405. Preparation And Evaluation Of Self-Microemulsifying Drug Delivery System Of Oridonin
  406. Preparation And In Vitro Anticancer Effect Of Oridonin Nanoparticles
  407. Preparation Of Oridonin-Loaded Mpeg-Pla Block Copolymer Micelles [J]
  408. Preparation Of Oridonin-Loaded Solid Lipid Nanoparticles And Studies On Them In Vitro And In Vivo
  409. Preparation, Characterization, And In Vitro And Vivo Antitumor Activity Of Oridonin-Conjugated Multiwalled Carbon Nanotubes Functionalized With Carboxylic Group
  410. Preparation, In Vitro, And In Vivo Antitumor Activity Of Folate Receptor‐Targeted Nanoliposomes Containing Oridonin
  411. Probing The Anticancer Action Of Oridonin With Fluorescent Analogues: Visualizing Subcellular Localization To Mitochondria
  412. Production Of Oridonin‐Rich Extracts From Rabdosia Rubescens Using Hyphenated Ultrasound‐Assisted Supercritical Carbon Dioxide Extraction
  413. Progress About Anti-Tumor Mechanism Of Oridonin [J]
  414. Protective Effects Of Oridonin On Acute Liver Injury Via Impeding Posttranslational Modifications Of Interleukin-1 Receptor-Associated Kinase 4 (Irak4) In The Toll-Like …
  415. Protective Effects Of Oridonin On The Sepsis In Mice
  416. Proteomic Analysis Of Oridonin-Induced Apoptosis In Multiple Myeloma Cells
  417. Proteomic And Functional Analyses Demonstrate The Involvement Of Oxidative Stress In The Anticancer Activities Of Oridonin In Hepg2 Cells
  418. Proteomic And Functional Analyses Reveal The Potential Involvement Of Endoplasmic Reticulum Stress And Α-Cp1 In The Anticancer Activities Of Oridonin In Hepg2 Cells
  419. Proteomic Identification Of Proteins Involved In The Anticancer Activities Of Oridonin In Hepg2 Cells
  420. Qualitative And Quantitative Analysis Of Ros-Mediated Oridonin-Induced Oesophageal Cancer Kyse-150 Cell Apoptosis By Atomic Force Microscopy
  421. Quantitative Determination Of Oridonin In Human Plasma By Rp-Hplc [J]
  422. Quantitative Determination Of Oridonin In Isodon Macrophyllus By Rp-Hplc
  423. Quantitative Determination Of Oridonin In The Rabdosia Rubescens Terpenoids Buccal Tablets By Hplc
  424. Radiosensitization Effect Of Oridonin On Hepg2 In Vitro
  425. Reactive Oxygen Species Contribute To Oridonin-Induced Apoptosis And Autophagy In Human Cervical Carcinoma Hela Cells
  426. Reactive Oxygen Species H2O2 And Oh, But Not O2− Promote Oridonin-Induced Phagocytosis Of Apoptotic Cells By Human Histocytic Lymphoma U937 Cells
  427. Reactive Oxygen Species Mediate Oridonin-Induced Apoptosis Through Dna Damage Response And Activation Of Jnk Pathway In Diffuse Large B Cell Lymphoma
  428. Reactive Oxygen Species Mediate Oridonin-Induced Hepg2 Apoptosis Through P53, Mapk, And Mitochondrial Signaling Pathways
  429. Recent Advances In The Molecular Basis Of Anti-Neoplastic Mechanisms Of Oridonin
  430. Recent Development Of Oridonin Derivatives With Diverse Pharmacological Activities
  431. Recent Progress Of Oridonin And Its Derivatives For The Treatment Of Acute Myelogenous Leukemia.
  432. Regio-And Stereospecific Synthesis Of Oridonin D-Ring Aziridinated Analogues For The Treatment Of Triple-Negative Breast Cancer Via Mediated Irreversible Covalent …
  433. Regulation Of Telomerase Activity And Cell Cycle By Oridonin In K562 Cells [J]
  434. Regulation Of Telomerase Activity And Cell Cycle Of K562 Cells By Oridonin
  435. Release Kinetics Of Oridonin Self-Microemulsifying Drug Delivery System In Vitro
  436. Research And Application In Nanoparticle Formulation Of Oridonin
  437. Resonance Light Scattering Technique As A New Tool To Determine The Binding Mode Of Anticancer Drug Oridonin To Dna
  438. Rgd-Modified Poly (D, L-Lactic Acid) Nanoparticles Enhance Tumor Targeting Of Oridonin
  439. Role Of Bcl-2 Family Members In Oridonin-Induced Apoptosis On Human Multiple Myeloma Cell [J]
  440. Role Of Endoplasmic Reticulum Stress Proteins Ire-1, Perk And Chop In Oridonin-Treated Hepg2 Cells [J]
  441. Roles Of Ras And Extracellular Signal-Regulated Kinase-Dependent Iκbα Degradation In Oridonin-Enhanced Phagocytosis Of Apoptotic Cells By Human Macrophage-Like …
  442. Ros/Jnk/C-Jun Axis Is Involved In Oridonin-Induced Caspase-Dependent Apoptosis In Human Colorectal Cancer Cells
  443. Selection For High Oridonin Yield In The Chinese Medicinal Plant Isodon (Lamiaceae) Using A Combined Phylogenetics And Population Genetics Approach
  444. Separation And Purification Of Oridonin By Macro-Porous Resin And Silica Column Chromatography
  445. Simultaneous Determination Of Ginsenoside Rb1, Naringin, Ginsenoside Rb2 And Oridonin In Rat Plasma By Lc–Ms/Ms And Its Application To A Pharmacokinetic Study …
  446. Simultaneous Determination Of Oridonin, Ponicidin And Rosmarinic Acid From Herba Isodi Rubescentis Extract By Lc–Ms-Ms In Rat Plasma
  447. Simultaneous Determination Of Rosmarinic Acid, Oridonin And Chrysoplenetin In Isodon Rubescens By Hplc
  448. Single Molecule Force Spectroscopy For In-Situ Probing Oridonin Inhibited Ros-Mediated Egf-Egfr Interactions In Living Kyse-150 Cells
  449. Solubility And Bioavailability Enhancement Of Oridonin: A Review
  450. Stimulation Of Suicidal Erythrocyte Death By Oridonin
  451. Structural Modification Of Oridonin Via Dast Induced Rearrangement
  452. Studies On Absorption Kinetics Of Oridonin In Rat Intestines [J]
  453. Studies On Pharmacokinetics And Tissue Distribution Of Oridonin Nanosuspensions
  454. Studies On Preparation And Property Of Oridonin Solid Lipid Nanoparticles
  455. Studies On The Cell-Immunosuppressive Mechanism Of Oridonin From Isodon Serra
  456. Studies On The Oridonin-Loaded Poly (D, L-Lactic Acid) Nanoparticles In Vitro And In Vivo
  457. Study Of Oridonin Inhibiting Proliferation Of Thyroid Carcinoma Cell Line Bcpap
  458. Study Of The Effet Of Oridonin And Bleomycin A_5 Combination Therapy On The Cell Cycle Of Ehrlich Carcinoma Cells By Means Of The Flow Cytometry
  459. Study Of The Role Of Hsp70. 1 In Oridonin-Treated Hepatocarcinoma Cells
  460. Study On Accumulation Mechanism Of Oridonin During Plant Regeneration In Rabdosia Rubescens [J]
  461. Study On Cyclin D/Rb/P16 Signal Pathway Of Bxpc-3 Cell Line Treated With Oridonin
  462. Study On Hpcl Detection For Drug Content And Entrapment Efficiency Of Oridonin Chitosan Microsphere
  463. Study On In Vitro Cytotoxicity And In Vivo Antitumor Effect Of Nanoliposomes Containing Oridonin
  464. Study On Inhibition Of Human Hl-60 Cell Growth By Oridonin [J]
  465. Study On Pharmacokinetics Of Oridonin In Mice
  466. Study On Reversal Effects Of Oridonin On Multidrug Resistant Cell Line K562/A02
  467. Study On Stability Of Oridonin Solution
  468. Study On The Antimutagenictty Of Oridonin [J]
  469. Study On The Anti-Tumor Effect Of Oridonin Self-Microemulsifying Drug Delivery System On Mouse H22 Hepatocellular Carcinoma In Vivo [J]
  470. Study On The Autophagy Of Prostate Cancer Pc‐3 Cells Induced By Oridonin
  471. Study On The Dynamics Of Spatial Accumulation Of Oridonin And Rosmarinic Acid Of Rabdosia Rubesens (Henmsl.) Hara
  472. Study On The Efficacy, Mechanism And Safety Of The Intravesical Instillation Of Oridonin And Rabdosia Rubescens Polysaccharide For C57Bl/6 Murine Bladder Cancer [J]
  473. Study On The Inclusion Of Oridonin-Beta-Cyclodextrin
  474. Study On The Inclusion Of Oridonin-Β-Cyclodextrin [J]
  475. Study On The Inhibitory Mechanism Of Oridonin In Pancreatic Cancers Bxpc-3 Cells By Dna Microarray
  476. Study On The Radiosensitization Effect Of Oridonin On Esophageal Cancer Stem Cell
  477. Study On The Ultrasonic Extraction Technology Of Oridonin
  478. Suppressive Effects Of Novel Oridonin Derivative Cyd0625 On Activated Hepatic Stellate Cells
  479. Synergistic Anticancer Effects Of Combined Γ-Tocotrienol And Oridonin Treatment Is Associated With The Induction Of Autophagy
  480. Synergistic Antitumor Activity Of Oridonin And Arsenic Trioxide On Hepatocellular Carcinoma Cells
  481. Synergistic Antitumor Activity Of Oridonin And Valproic Acid On Hl‐60 Leukemia Cells
  482. Synergistic Compositions Consisting Essentially Of Combinations Of Active Agents Selected From Oridonin, Wogonin, And Isoliquiritigenin For The Prevention Of Neoplasia
  483. Synergistic Effect Of Oridonin And A Pi3K/Mtor Inhibitor On The Non-Germinal Center B Cell-Like Subtype Of Diffuse Large B Cell Lymphoma
  484. Synergistic Effect Of Oridonin And Cisplatin On Cytotoxicity And Dna Cross-Link Against Mouse Sarcoma S180 Cells In Culture.
  485. Synergistic Suppression Of T (8; 21)-Positive Leukemia Cell Growth By Combining Oridonin And Mapk1/Erk2 Inhibitors
  486. Synthesis And Antimycobacterial Evaluation Of Natural Oridonin And Its Enmein-Type Derivatives
  487. Synthesis And Biological Evaluation Of Novel 1-O-And 14-O-Derivatives Of Oridonin As Potential Anticancer Drug Candidates
  488. Synthesis And Biological Evaluation Of Novel Furozan-Based Nitric Oxide-Releasing Derivatives Of Oridonin As Potential Anti-Tumor Agents
  489. Synthesis And Biological Evaluation Of Novel Jiyuan Oridonin A-1, 2, 3-Triazole-Azole Derivatives As Antiproliferative Agents
  490. Synthesis Of Oridonin Derivatives And Their Inhibition On T (8; 21) Leukemia
  491. Synthesis Of Oridonin Derivatives Via Mizoroki-Heck Reaction And Click Chemistry For Cytotoxic Activity
  492. Synthesis Of Spirolactone-Type Diterpenoid Derivatives From Kaurene-Type Oridonin With Improved Antiproliferative Effects And Their Apoptosis-Inducing Activity In Human …
  493. Synthesis, And Evaluation Of In Vitro And In Vivo Anticancer Activity Of 14-Substituted Oridonin Analogs: A Novel And Potent Cell Cycle Arrest And Apoptosis Inducer …
  494. Synthesis, Characterization, In Vitro And In Vivo Evaluation Of Pegylated Oridonin Conjugates
  495. Targeting 3-Phosphoinositide-Dependent Protein Kinase 1 Associated With Drug-Resistant Renal Cell Carcinoma Using New Oridonin Analogs
  496. Targeting Akt With Oridonin Inhibits Growth Of Esophageal Squamous Cell Carcinoma In Vitro And Patient-Derived Xenografts In Vivo
  497. Targeting Of Aml1-Eto In T (8; 21) Leukemia By Oridonin Generates A Tumor Suppressor–Like Protein
  498. Targeting Xbp1-Mediated Β-Catenin Expression Associated With Bladder Cancer With Newly Synthetic Oridonin Analogues
  499. Terpenoids. Part Xv. Structure And Absolute Configuration Of Oridonin Isolated From Isodon Japonicus And Isodon Trichocarpus
  500. Terpenoids. Part Xvi. Chemical Conversion Of Oridonin Into Isodocarpin
  501. The Antibacterial Mechanism Of Oridonin Against Methicillin-Resistant Staphylococcus Aureus (Mrsa)
  502. The Anticancer Effect Of Oridonin Is Mediated By Fatty Acid Synthase Suppression In Human Colorectal Cancer Cells
  503. The Anti-Tumor Diterpene Oridonin Is A Direct Inhibitor Of Nucleolin In Cancer Cells
  504. The Anti-Tumor Effect Of Folate-Targeted Liposome Microbubbles Loaded With Oridonin As Ultrasound-Triggered Tumor-Targeted Therapeutic Carrier System
  505. The Cell Death Of C6 Astrocytoma Cells Induced By Oridonin And Its Mechanism
  506. The Conversion Of Oridonin To Spirolactone-Type Or Enmein-Type Diterpenoid: Synthesis And Biological Evaluation Of Ent-6, 7-Seco-Oridonin Derivatives As Novel …
  507. The Cytostatic And Cytotoxic Effects Of Oridonin (Rubescenin), A Diterpenoid From Rabdosia Rubescens, On Tumor Cells Of Different Lineage
  508. The Effect Of Oridonin On Dna Damage In The Mammalian Cells
  509. The Effect Of Oridonin On The Incorporation Of [~ 3H] Tdr,[~ 3H] Ur And [~ 3H] Leucine Into The Eca Cells In Vitro
  510. The Effect Of Stealth Liposomes On Pharmacokinetics, Tissue Distribution And Anti-Tumor Activity Of Oridonin
  511. The Effects Of Oridonin On Cell Growth, Cell Cycle, Cell Migration And Differentiation In Melanoma Cells
  512. The Inhibitory And Apoptosis Effect Of Oridonin On Human Lung Adenocarcinoma Spc-A-1
  513. The Inhibitory Effect Of Oridonin On Colon Cancer Was Mediated By Deactivation Of Tgf-Β1/Smads-Pai-1 Signaling Pathway In Vitro And Vivo
  514. The Inhibitory Effect Of Oridonin On The Growth Of Fifteen Human Cancer Cell Lines
  515. The Inhibitory Mechanism Of Down-Regulation Expression Of Pp-Galnac-T14 By Oridonin On Human Renal Carcinoma Cells In Vitro [J]
  516. The Mechanism Of Proliferative Inhibition Of Acanthopanax Senticosus And Oridonin For Eca-109 Cells [J]
  517. The Study Of Anticancer Values Of Oridonin For Microsatellite Instability Colorectal Cancer [J]
  518. The Tissue Distribution In Mice And Pharmacokinetics In Rabbits Of Oridonin-Solid Lipid Nanoparticles
  519. The Tyrphostin Ag1478 Augments Oridonin-Induced A431 Cell Apoptosis By Blockage Of Jnk Mapk And Enhancement Of Oxidative Stress
  520. Therapeutic Effect Of Oridonin On Mice With Prostate Cancer
  521. Therapeutic Potential Of Oridonin And Its Analogs: From Anticancer And Antiinflammation To Neuroprotection
  522. Tlc In Quantitative Determination Of Oridonin And Ponicidin In The Leaves Of Rabdosia Rubescens
  523. Total Synthesis Of (−)-Oridonin: An Interrupted-Nazarov Approach
  524. Triggering Fbw7-Mediated Proteasomal Degradation Of C-Myc By Oridonin Induces Cell Growth
  525. Triggering Fbw7-Mediated Proteasomal Degradation Of C-Myc By Oridonin Induces Cell Growth Inhibition And Apoptosis
  526. Ultrasound‐Assisted Extraction Followed By Rp‐Hplc Separation For The Simultaneous Determination Of Oleanolic Acid, Ursolic Acid And Oridonin Content In Rabdosia …
  527. Zirconium-Porphyrin Pcn-222: Ph-Responsive Controlled Anticancer Drug Oridonin

Related Posts

Shopping Cart
Scroll to Top